Sort
48,018 grants matching “immunotherapy”
Rapid response for pandemics: single cell sequencing and deep learning to predict antibody sequences against an emerging antigen
$1,851,627Animesh Ray · Keck Graduate Inst Of Applied Life Scis · R01 · FY2021 · AI
Development of antibody engineering-based cancer therapies
$1,851,352Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
BIOLOGICAL APPROACHES TO THE TREATMENT OF CANCER
$1,850,521Sloan-Kettering Institute For Cancer Res · P01 · FY2003 · CA
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
$1,850,296Vinod P Balachandran · Sloan-Kettering Inst Can Research · U01 · FY2017 · CA
Development of new antibody-based cancer therapies
$1,849,077Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
$1,849,047Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2025 · AG
Combination immunotherapy with gene modified CD4 and CD8 T cells and stem cells
$1,848,744Carl H. June · University Of Pennsylvania · U19 · FY2010 · AI
Genes and signals controlling mammalian hematopoiesis.
$1,848,628Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$1,848,151Roger L Shapiro · Harvard School Of Public Health · U01 · FY2020 · AI
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system
$1,847,560Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$1,847,460Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Innate Immunity: Elucidation/Modulation - Cancer Therapy
$1,847,245Ohio State University · P01 · FY2002 · CA
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge
$1,846,796Brenda Marie Sandmaier · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection
$1,846,478Nicholas J Mantis · Nysdoh/Health Research, Inc. · N01 · FY2021 · AI
Hematopoietic Chimerism after Stem Cell Allografts
$1,846,366Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA
Innate Immunity: Elucidation/Modulation - Cancer Therapy
$1,846,087Ohio State University · P01 · FY2003 · CA
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$1,845,545Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Center for Immunotherapeutic Transport Oncophysics
$1,845,151Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2017 · CA
Blood Stem Cell Transplantation as Immunotherapy
$1,845,101Samuel Strober · Stanford University · P01 · FY2014 · HL
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
$1,845,039William C Hahn · Dana-Farber Cancer Inst · U01 · FY2017 · CA
Blood Stem Cell Transplantation as Immunotherapy
$1,844,916Samuel Strober · Stanford University · P01 · FY2008 · HL
Noroviruses and Epidemic Gastroenteritis
$1,844,686Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
A Methamphetamine Conjugate Vaccine: From Manufacturing to IND
$1,843,400Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2015 · DA
VPS72 controls Treg cell stability and adaptation to tumor microenvironment
$1,843,396Qing-Sheng Mi · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · CA
ADULT AIDS CLINICAL TRIAL UNIT
$1,842,655University Of Texas Medical Br Galveston · U01 · FY2001 · AI